TARO

Taro Pharmaceutical Industries Ltd.
TARO

Overview Fund Activity
Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

61 hedge funds and large institutions have $105M invested in Taro Pharmaceutical Industries Ltd. in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 15 closing their positions.

Holders
61
Holders Change
-9
Holders Change %
-12.86%
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
20
Reduced
19
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Ameriprise
1
Ameriprise
Minnesota
$8.1M
2
CAC
2
Cowen and Company
New York
$2.05M
3
KAM
3
Krensavage Asset Management
New York
$18.7M
4
Hotchkis & Wiley Capital Management
4
Hotchkis & Wiley Capital Management
California
$8.11M
5
SFO
5
Stokes Family Office
Louisiana
$308K

Top Sellers

1
AC
1
Armistice Capital
New York
$0
2
M
2
Murchinson
Ontario, Canada
$3.08M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$17.8M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$20.2K
5
Millennium Management
5
Millennium Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
76
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$0 3 +2 +200%
SFG
78
Steward Financial Group
Texas
$0 5 +5 New
1 2 3
4